200 related articles for article (PubMed ID: 24884675)
1. Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.
Rooney L; Vidal A; D'Souza AM; Devereux N; Masick B; Boissel V; West R; Head V; Stringer R; Lao J; Petrus MJ; Patapoutian A; Nash M; Stoakley N; Panesar M; Verkuyl JM; Schumacher AM; Petrassi HM; Tully DC
J Med Chem; 2014 Jun; 57(12):5129-40. PubMed ID: 24884675
[TBL] [Abstract][Full Text] [Related]
2. Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.
Schenkel LB; Olivieri PR; Boezio AA; Deak HL; Emkey R; Graceffa RF; Gunaydin H; Guzman-Perez A; Lee JH; Teffera Y; Wang W; Youngblood BD; Yu VL; Zhang M; Gavva NR; Lehto SG; Geuns-Meyer S
J Med Chem; 2016 Mar; 59(6):2794-809. PubMed ID: 26942860
[TBL] [Abstract][Full Text] [Related]
3. The pore-domain of TRPA1 mediates the inhibitory effect of the antagonist 6-methyl-5-(2-(trifluoromethyl)phenyl)-1H-indazole.
Moldenhauer H; Latorre R; Grandl J
PLoS One; 2014; 9(9):e106776. PubMed ID: 25181545
[TBL] [Abstract][Full Text] [Related]
4. Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.
Gijsen HJ; Berthelot D; De Cleyn MA; Geuens I; Brône B; Mercken M
Bioorg Med Chem Lett; 2012 Jan; 22(2):797-800. PubMed ID: 22222037
[TBL] [Abstract][Full Text] [Related]
5. Selective antagonism of TRPA1 produces limited efficacy in models of inflammatory- and neuropathic-induced mechanical hypersensitivity in rats.
Lehto SG; Weyer AD; Youngblood BD; Zhang M; Yin R; Wang W; Teffera Y; Cooke M; Stucky CL; Schenkel L; Geuns-Meyer S; Moyer BD; Wild KD; Gavva NR
Mol Pain; 2016; 12():. PubMed ID: 27899696
[TBL] [Abstract][Full Text] [Related]
6. 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
Baraldi PG; Romagnoli R; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Pedretti P; Fusi C; Nassini R; Materazzi S; Geppetti P; Preti D
Bioorg Med Chem; 2012 Mar; 20(5):1690-8. PubMed ID: 22325155
[TBL] [Abstract][Full Text] [Related]
7. Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.
Copeland KW; Boezio AA; Cheung E; Lee J; Olivieri P; Schenkel LB; Wan Q; Wang W; Wells MC; Youngblood B; Gavva NR; Lehto SG; Geuns-Meyer S
Bioorg Med Chem Lett; 2014 Aug; 24(15):3464-8. PubMed ID: 24953819
[TBL] [Abstract][Full Text] [Related]
8. In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 antagonists.
Perner RJ; DiDomenico S; Koenig JR; Gomtsyan A; Bayburt EK; Schmidt RG; Drizin I; Zheng GZ; Turner SC; Jinkerson T; Brown BS; Keddy RG; Lukin K; McDonald HA; Honore P; Mikusa J; Marsh KC; Wetter JM; George KS; Jarvis MF; Faltynek CR; Lee CH
J Med Chem; 2007 Jul; 50(15):3651-60. PubMed ID: 17583335
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamides as TRPA1 antagonists.
Laliberté S; Vallée F; Fournier PA; Bedard L; Labrecque J; Albert JS
Bioorg Med Chem Lett; 2014 Jul; 24(14):3204-6. PubMed ID: 24880903
[TBL] [Abstract][Full Text] [Related]
10. Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep).
Parsons WH; Calvo RR; Cheung W; Lee YK; Patel S; Liu J; Youngman MA; Dax SL; Stone D; Qin N; Hutchinson T; Lubin ML; Zhang SP; Finley M; Liu Y; Brandt MR; Flores CM; Player MR
J Med Chem; 2015 May; 58(9):3859-74. PubMed ID: 25850459
[TBL] [Abstract][Full Text] [Related]
11. Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles.
Ognyanov VI; Balan C; Bannon AW; Bo Y; Dominguez C; Fotsch C; Gore VK; Klionsky L; Ma VV; Qian YX; Tamir R; Wang X; Xi N; Xu S; Zhu D; Gavva NR; Treanor JJ; Norman MH
J Med Chem; 2006 Jun; 49(12):3719-42. PubMed ID: 16759115
[TBL] [Abstract][Full Text] [Related]
12. Identification of natural compound carnosol as a novel TRPA1 receptor agonist.
Zhai C; Liu Q; Zhang Y; Wang S; Zhang Y; Li S; Qiao Y
Molecules; 2014 Nov; 19(11):18733-46. PubMed ID: 25405290
[TBL] [Abstract][Full Text] [Related]
13. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
[TBL] [Abstract][Full Text] [Related]
14. Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activation.
Lee KJ; Wang W; Padaki R; Bi V; Plewa CA; Gavva NR
J Pharmacol Exp Ther; 2014 Aug; 350(2):223-31. PubMed ID: 24893987
[TBL] [Abstract][Full Text] [Related]
15. Activation of transient receptor potential ankyrin 1 by eugenol.
Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
[TBL] [Abstract][Full Text] [Related]
16. The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives.
Nassini R; Fusi C; Materazzi S; Coppi E; Tuccinardi T; Marone IM; De Logu F; Preti D; Tonello R; Chiarugi A; Patacchini R; Geppetti P; Benemei S
Br J Pharmacol; 2015 Jul; 172(13):3397-411. PubMed ID: 25765567
[TBL] [Abstract][Full Text] [Related]
17. N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor.
Vallin KS; Sterky KJ; Nyman E; Bernström J; From R; Linde C; Minidis AB; Nolting A; Närhi K; Santangelo EM; Sehgelmeble FW; Sohn D; Strindlund J; Weigelt D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5485-92. PubMed ID: 22868228
[TBL] [Abstract][Full Text] [Related]
18. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
Norman MH; Zhu J; Fotsch C; Bo Y; Chen N; Chakrabarti P; Doherty EM; Gavva NR; Nishimura N; Nixey T; Ognyanov VI; Rzasa RM; Stec M; Surapaneni S; Tamir R; Viswanadhan VN; Treanor JJ
J Med Chem; 2007 Jul; 50(15):3497-514. PubMed ID: 17585749
[TBL] [Abstract][Full Text] [Related]
19. TRPA1 antagonists as potential analgesic drugs.
Andrade EL; Meotti FC; Calixto JB
Pharmacol Ther; 2012 Feb; 133(2):189-204. PubMed ID: 22119554
[TBL] [Abstract][Full Text] [Related]
20. Chalcone Derivatives Activate and Desensitize the Transient Receptor Potential Ankyrin 1 Cation Channel, Subfamily A, Member 1 TRPA1 Ion Channel: Structure-Activity Relationships in vitro and Anti-Nociceptive and Anti-inflammatory Activity in vivo.
Moriello AS; Luongo L; Guida F; Christodoulou MS; Perdicchia D; Maione S; Passarella D; Marzo VD; Petrocellis L
CNS Neurol Disord Drug Targets; 2016; 15(8):987-994. PubMed ID: 27071783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
